(ovarian cancer) Clinigen Release Company Initiates U S Managed Access Program For Tesaros Niraparib Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, January 17, 2017

(ovarian cancer) Clinigen Release Company Initiates U S Managed Access Program For Tesaros Niraparib



Clinigen Release Company Initiates U S Managed Access Program For Tesaros Niraparib For Patients With Ovarian Cancer

1/17/2017
  The Managed Access program allows physicians to request niraparib for individual, eligible U.S. patients who may not be able to participate in a clinical trial nor have any other treatment option, but who may benefit from access to this investigational therapy prior to approval.

0 comments :

Post a Comment

Your comments?